Comments for FDA Extreme Trades: 16 Stocks Under $5 at http://www.biomedreports.com , comment 1 to 5 out of 5 comments http://www.biomedreports.com Wed, 08 Feb 2012 17:01:07 +0100 FeedCreator 1.7.3 http://www.biomedreports.com/200906271673/fda-extreme-trades-16-stocks-under-5.html#comment-438 Please contact the author (Justin Hall) of the articles on Spectrum Pharma (SPPI) regarding specific questions -- there is a link to his email at the end of all the articles he has contributed. - Mike Havrilla Tue, 30 Jun 2009 11:46:34 +0100 http://www.biomedreports.com/200906271673/fda-extreme-trades-16-stocks-under-5.html#comment-432 Mike, Your assessment of SPPI being bought by Bayer seems to hinge on the success of Zevalin. If the nay sayers are correct about Zevalin and it does not offer a significant benefit or fails to gain market share, what weight is then placed on their (SPPI) pipeline; Ozarelix, Ortataxer, Sartraplatin et al and could these therapeutics alone hold the attention of Bayer or another buyer? - mikenj Tue, 30 Jun 2009 04:09:29 +0100 http://www.biomedreports.com/200906271673/fda-extreme-trades-16-stocks-under-5.html#comment-426 SPPI IS UP FOR EVALUATION ON 7/3 CORRECT ? WILL THAT BE IN THE MORNING USUALLY BEFORE THE MARKET ? IT SEEMS THAT SPPI WILL GET THE NOD, UPSIDE IS WHAT ? IN YOUR OPIOION ? 10 - 15 ? THANKS! - RICH Mon, 29 Jun 2009 07:08:25 +0100 http://www.biomedreports.com/200906271673/fda-extreme-trades-16-stocks-under-5.html#comment-414 Hey Mike, I am an avid follower of both your Seeking Alpha articles and Biomedreports.com work as well. I am fairly new to investing but your articles have really peaked my interest in the exciting yet volatile world of Bio-tech stocks. Thanks for your hard work and ideas. I have done a bit of research on Nephros (neph) and understand they have multiple approvals pending with the FDA. Many people feel like there is a good chance for approval and that it could be coming fairly soon. What are your personal feelings concerning Neph and FDA Approval? Also I hvae really been interested in BDSI and just wondering if I may have missed my opportunity at a good entry point after Friday's gains. Thanks. - Dan Brokaw Sat, 27 Jun 2009 14:13:29 +0100 http://www.biomedreports.com/200906271673/fda-extreme-trades-16-stocks-under-5.html#comment-411 Any of you noticed EKO-to pending FDA The only masks and respirators with antibacterial agents that destroy viruses should revolutionize the ppe medical device industry! Patents world wide for another 18years! http://www.noveko.com/en/index.cfm Ce approuved,health canada approuved! Last chance at 2.10 cnd. - Marcello Romani Sat, 27 Jun 2009 06:12:41 +0100